Samsara BioCapital as of June 30, 2024
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 40 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cargo Therapeutics (CRGX) | 15.2 | $73M | 4.4M | 16.42 | |
| Mineralys Therapeutics (MLYS) | 12.4 | $59M | 5.1M | 11.70 | |
| Scholar Rock Hldg Corp (SRRK) | 11.8 | $57M | 6.8M | 8.33 | |
| Neurogene (NGNE) | 9.7 | $46M | 1.3M | 36.39 | |
| Arcellx Common Stock (ACLX) | 5.2 | $25M | 454k | 55.19 | |
| Eliem Therapeutics (CLYM) | 4.9 | $23M | 3.3M | 7.11 | |
| Nkarta (NKTX) | 4.7 | $22M | 3.8M | 5.91 | |
| Lenz Therapeutics (LENZ) | 4.4 | $21M | 1.2M | 17.29 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 2.8 | $14M | 968k | 14.06 | |
| Jasper Therapeutics Com New (JSPR) | 2.5 | $12M | 525k | 22.70 | |
| Hillevax | 2.4 | $12M | 799k | 14.46 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.4 | $11M | 850k | 13.22 | |
| Acelyrin | 2.3 | $11M | 2.5M | 4.41 | |
| Contineum Therapeutics Cl A (CTNM) | 2.2 | $10M | 589k | 17.61 | |
| Syros Pharmaceuticals Com New (SYRS) | 1.9 | $9.2M | 1.8M | 5.16 | |
| Zymeworks Del (ZYME) | 1.8 | $8.5M | 1.0M | 8.51 | |
| Rhythm Pharmaceuticals (RYTM) | 1.5 | $7.1M | 173k | 41.06 | |
| Inozyme Pharma (INZY) | 1.5 | $7.0M | 1.6M | 4.46 | |
| Sutro Biopharma (STRO) | 1.3 | $6.4M | 2.2M | 2.93 | |
| Gossamer Bio (GOSS) | 1.2 | $5.5M | 6.1M | 0.90 | |
| Tango Therapeutics (TNGX) | 1.1 | $5.4M | 630k | 8.58 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $5.0M | 348k | 14.46 | |
| Leap Therapeutics Com New (LPTX) | 1.0 | $4.8M | 2.4M | 1.96 | |
| Io Biotech (IOBT) | 0.9 | $4.3M | 3.6M | 1.17 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.8 | $3.7M | 207k | 17.66 | |
| Prime Medicine (PRME) | 0.6 | $2.8M | 540k | 5.14 | |
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $2.7M | 196k | 13.78 | |
| Immatics SHS (IMTX) | 0.5 | $2.3M | 198k | 11.62 | |
| Janux Therapeutics (JANX) | 0.4 | $1.9M | 45k | 41.89 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $1.4M | 202k | 6.81 | |
| Igm Biosciences (IGMS) | 0.2 | $1.1M | 155k | 6.87 | |
| Bolt Biotherapeutics | 0.2 | $787k | 1.0M | 0.75 | |
| Lyra Therapeutics | 0.2 | $769k | 2.8M | 0.28 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $766k | 696k | 1.10 | |
| Viracta Therapeutics (VIRX) | 0.1 | $375k | 690k | 0.54 | |
| Allakos | 0.0 | $172k | 172k | 1.00 | |
| Kronos Bio | 0.0 | $97k | 78k | 1.24 | |
| Allovir (ALVR) | 0.0 | $60k | 82k | 0.72 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $21k | 133k | 0.16 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.7k | 100k | 0.02 |
